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A B S T R A C T
Passage of malaria parasites through mosquitoes involves multiple developmental transitions, from gametocytes that are ingested with the blood meal, through to
sporozoites that are transmitted by insect bite to the host. During the transformation from gametocyte to oocyst, the parasite forms a unique transient organelle
named the crystalloid, which is involved in sporozoite formation. In Plasmodium berghei, a complex of six LCCL domain-containing proteins (LAPs) reside in the
crystalloid and are required for its biogenesis. However, little else is known about the molecular mechanisms that underlie the crystalloid's role in sporogony. In this
study, we have used transgenic parasites stably expressing LAP3 fused to GFP, combined with GFP affinity pulldown and high accuracy mass spectrometry, to identify
an extended LAP interactome of some fifty proteins. We show that many of these are targeted to the crystalloid, including members of two protein families with CPW-
WPC and pleckstrin homology-like domains, respectively. Our findings indicate that the LAPs are part of an intricate protein complex, the formation of which
facilitates both crystalloid targeting and biogenesis.
Significance: Reducing malaria parasite transmission by mosquitoes is a key component of malaria eradication and control strategies. This study sheds important new
light on the molecular composition of the crystalloid, an enigmatic parasite organelle that is essential for sporozoite formation and transmission from the insect to the
vertebrate host. Our findings provide new mechanistic insight into how proteins are delivered to the crystalloid, and indicate that the molecular mechanisms that
underlie crystalloid function are complex, involving several protein families unique to Plasmodium and closely related organisms. The new crystalloid proteins
identified will form a useful starting point for studies aimed at unravelling how the crystalloid organelle facilitates sporogony and transmission.
1. Introduction
Despite a significant fall in incidence rates in the last decade, ma-
laria remains the most serious parasitic infection in humans. In 2018,
the disease caused an estimated 228 million cases and 405,000 deaths,
mostly in the under-fives. Malaria prophylaxis, treatment and control
efforts continue to suffer from widespread resistance to anti-malarial
drugs and insecticides, underpinning the urgent need for new therapies
not only for prevention and treatment of the human disease, but also for
reducing transmission, which will contribute to the global effort of
malaria control and eradication. Malaria parasite transmission is in-
itiated when Anopheles female mosquitoes ingest blood-borne gameto-
cytes during blood feeding on a parasite-infected host. This sets off a
rapid process of gamete formation and fertilization in the insect midgut.
Zygotes undergo meiosis and transform into motile elongated forms
called ookinetes that cross the midgut epithelium and round up to form
young oocysts. In the following weeks, oocysts grow and divide by a
process called sporogony, generating thousands of haploid sporozoites.
These make their way to the insect's salivary glands to be transmitted to
new hosts by mosquito bite. Parasites first multiply in liver cells to
produce thousands of merozoites, which initiate new blood stage
parasite infections. A small percentage of intraerythrocytic parasites
transform into gametocytes to complete the life cycle.
In P. berghei, successful sporogony and sporozoite transmission re-
quires expression of a family of six modular proteins rich in putative
carbohydrate binding domains, named LCCL lectin adhesive-like pro-
teins (LAPs) [1–6]. The LAP-encoding genes are expressed in female
gametocytes and are maternally inherited, and their gene products
operate as a protein complex [3,7–9]. Another shared feature of the
LAPs is their subcellular localization in the crystalloid, an unusual
multivesicular organelle found exclusively in the ookinete and young
oocysts life stages of the parasite [4,10–13]. The crystalloid organelle
forms after fertilization, during zygote transformation into ookinete and
then oocyst, by a process of active transport and assembly of en-
doplasmic reticulum (ER)-derived vesicles [2]. Disruption of lap genes
in P. berghei gives rise to similar loss-of-function phenotypes char-
acterised by a failure of the oocysts to generate sporozoites [1–4,14].
Disruption or mutation of the LAPs affects formation of the
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crystalloids [2,4,7,15], identifying a link between LAP expression and
crystalloid biogenesis. However, the role of the LAPs in sporozoite
formation in the oocyst (sporogony) is much less clear. The LAPs are not
expressed during sporozoite budding [4,14], and it is possible that their
loss-of-function phenotype in the oocyst is in fact caused by the absence
of the crystalloid and the broader protein repertoire contained within it,
rather than by the absence of individual LAP molecules. This concept is
supported by recent reports that null mutants of other crystalloid-re-
sident proteins structurally and functionally unrelated to the LAPs, such
as the S-acyl transferase DHHC10 and a membrane bound NAD(P)
transhydrogenase (NTH), phenocopy the LAP null mutants [16,17].
This led to the hypothesis that the process of the crystalloid vesicles
budding off the ER, a key step in crystalloid organelle formation [2], is
at least partly dependent on the physical presence of the proteins
contained within them (i.e. the crystalloid ‘cargo’) [2,18]. To shed
further light on the underlying molecular mechanisms by which the
crystalloids facilitate sporogony, we have here determined an extended
LAP interactome and show that it contains many new crystalloid pro-
teins. The biological significance of these findings is discussed.
2. Materials and methods
2.1. Parasite maintenance, culture, and purification
P. berghei ANKA clone 2.34 parasites were maintained as cryopre-
served stabilates or by mechanical blood passage and regular mosquito
transmission. Ookinete cultures were set up overnight from gametocy-
temic blood as previously described [19]. After 20-24 h, ookinetes were
purified by ice-cold 0.17M ammonium chloride lysis and centrifugation
at 800×g for 15min, followed by three washes in PBS with cen-
trifugation at 500×g.
2.2. Immuno-affinity capture and in vivo crosslinking
Immuno-affinity capture of GFP fusion proteins was carried out by
GFP pull-down using the μMACS GFP tagged protein isolation kit
(Miltenyi Biotec) according to manufacturer's instructions. Briefly, 5–10
million purified parasites were lysed in 1ml of pre-cooled lysis buffer
(150mM NaCl, 1% Triton X-100, 50mM Tris-HCl pH 8.0) and in-
cubated on ice for 30min. Cell debris was removed by centrifugation at
10,000×g. Fifty μl anti-GFP microbeads were added to the supernatant
and the mixture incubated on ice for 30min to allow antibody binding.
The cell lysate was then run by gravity through a magnetic micro-
column to capture the magnetic microbeads, followed by four 200 μl
washes with lysis buffer. Proteins were eluted in 50 μl pre-heated 95 °C
elution buffer (50mM Tris-HCl pH 6.8, 50mM DTT, 1% SDS, 1mM
EDTA, 0.005% bromophenol blue, 10% glycerol) and frozen until fur-
ther use. For in vivo crosslinking, purified ookinetes were collected by
low speed centrifugation (0.8 xg), resuspended in 0.5 ml PBS supple-
mented with 1% (w/v) paraformaldehyde and incubated at room tem-
perature. The cells were collected by centrifugation after a total of
10min in the fixative (including centrifugation), resuspended in 0.5 ml
250mM Tris-HCl (pH 7.2), and incubated 10min at room temperature
to quench the formaldehyde. Cells were again collected by centrifuga-
tion followed by cell lysis and GFP pull-down as described.
2.3. Sample preparation for mass spectrometry
Four replicates each of crosslinked and non-crosslinked LAP3/GFP
pulldown samples were analysed, as well as two replicates of LAP3-KO
pulldown samples as negative controls. Protein samples in SDS sample
buffer were digested with trypsin by a modified version of the filter-
aided sample preparation (FASP) procedure of in solution digestion
[20]. Samples were reduced in sample buffer with 100mM DTT for
3min at 95 before centrifuging them in Amicon Ultra filter tubes
(30 kDa cut off) for 15min at 16000 g and subsequent dilution of
samples with 300ul of 50mM ABC buffer. Samples were centrifuged
once more to ensure maximal removal of DTT and SDS followed by
alkylation step with 50mM of 2-chloroacetamide (Sigma). Single step
overnight trypsin digestion at enzyme to substrate ratio of 1:100 was
carried out at 37 °C. Tryptic digests were acidified to a final con-
centration of 0.1% TFA and purified by STAGE tips [21].
2.4. Liquid chromatography tandem mass spectrometry
Peptide digest samples were analysed by an LC-MS/MS platform
composed of the Ultimate 3000 UPLC (Thermo Fisher, Germany) con-
nected to the Orbitrap Velos Pro mass spectrometer (Thermo Fisher,
Germany) for acquiring tandem mass spectrometry data. Peptide sam-
ples were loaded on a 2 cm Acclaim™ PepMap™100 Nano-Trap Column
(Thermo Fisher, Germany) and were separated by a 25 cm Acclaim™
PepMap™100 Nano LC column (Thermo Fisher, Germany) packed with
3 μm C18 beads with a flow-rate of 300 nl/min in a 120min gradient of
95% buffer A/5% buffer B to 65% buffer A /35% buffer B (buffer A:
0.5% acetic acid. Buffer B: 0.5% acetic acid in 100% acetonitrile).
Peptides eluting from the column were ionised and injected into the
mass spectrometer at 2.3 kV spray voltage. The Orbitrap mass spec-
trometer operated in a data-dependent mode and switched between MS
and MS2 automatically by a top 10 method. The Orbitrap cell acquired
full-scan spectra of intact peptides (m/z 350–1500) with automated
gain control accumulation value of 1.000.000 ion and with a resolution
of 60.000. The ten most abundant ions were sequentially isolated and
fragmented in the linear ion trap, where dissociation was induced
through collision, using an accumulation target value of 10.000, a
normalized collision energy of 35% and a capillary temperature of
275 °C. Dynamic exclusion of ions sequenced within the 45 previous
seconds was applied. Unassigned charge states and singly charged ions
were excluded from sequencing. For MS2 selection, a minimum of
10.000 counts was required.
2.5. Protein identification and quantification
Tandem mass spectrometry data was searched by Andromeda [22]
search engine integrated in MaxQuant (Version 1.5.3.8) [23] for protein
identification. Peak lists were generated for the top 12 most intense MS
peaks in 100 Da windows by MaxQuant prior to the database search. The
protein database contained protein sequences from P. berghei (http://
plasmodb.org/common/downloads/release-29/PbergheiANKA/fasta/
data/) and from mouse (http://www.uniprot.org/downloads, down-
loaded at 2 November 2016) supplemented with frequently observed
contaminants. Andromeda search parameters for protein identification
were set to tolerance of 6 ppm for the parental peptide and 0.5 Da for
fragmentation spectra and trypsin specificity allowing up to 2 miscleaved
sites. Deamination of glutamine, oxidation of methionine, and asparagine
and protein N-terminal acetylation were set as variable modifications,
carboxyamidomethylation of cysteines was specified as a fixed mod-
ification. Minimal required peptide length was specified at 7 amino
acids. Peptides and proteins detected with a false discovery rate (FDR) of
1% were accepted. Excluded from validation were proteins identified by
site only, external contaminants and reversed proteins. Proteins were
quantified by normalized summed peptide intensities [24] computed in
MaxQuant with the label free quantification (LFQ) option switched on.
Hierarchical clustering of relative LFQ profiles ranging from 0 to 1 was
performed in Perseus 1.3.7.1 [25].
2.6. Bioinformatics filters
Protein outputs were subjected to the following bioinformatics fil-
ters: (1) Absence of a predicted amino-terminal ER signal peptide (SP-
HMM algorithm); (2) Presence of a predicted carboxy-terminal ER re-
tention signal (XDEL) for predicted luminal proteins (one letter amino
acid code, X= any amino acid); (3) Transcript level ratio gametocytes/
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asexual stages ≤1 [26]; (4) Transcript level ratio female gametocyte/
male gametocyte ≤1 [27].
2.7. Data availability
The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium (http://proteomecentral.proteomexchange.
org) via the PRIDE partner repository [28] with the dataset identifier
PXD019454.
2.8. Animal experiments
All laboratory animal work was carried out in accordance with the
Arrive guidelines and the United Kingdom Animals (Scientific
Procedures) Act 1986 implementing European Directive 2010/63/EU
for animal experiments. Experiments were generally conducted in
6–8 weeks old female CD1 mice, specific pathogen free and maintained
in filter cages. Animal welfare was assessed daily and animals were
humanely killed upon reaching experimental or clinical endpoints. Mice
were infected with parasites suspended in phosphate buffered saline
(PBS) by intraperitoneal injection, or by infected mosquito bite on an-
aesthetized animals. Intra-erythrocytic parasitemia was monitored
regularly by collecting of a small volume of blood from a superficial tail
vein. Drugs were administered by intraperitoneal injection or where
possible were supplied in drinking water. Parasitized blood was har-
vested by cardiac bleed under general anaesthesia without recovery.
2.9. Generation of CPW-WPC protein targeting constructs
An approximately 2.2 kb fragment corresponding to the coding se-
quence and 5’UTR of PBANKA_0943400 was PCR amplified from P.
berghei genomic DNA with primers CPW1-F (TTGGGCTGCAGTCGAGC
AAGGGACTGTAATGGTGA) and CPW1-R (ATGAGGGCCCCTAAGCTCT
CTAAGGTGATCCCTTTTTTGTTTG) and cloned into SalI/HindIII-
digested plasmid pBS-EGFP-hDHFR to give pBS-CPW1/GFP. The
plasmid was linearized with HindIII before gene targeting by single
crossover homologous recombination.
An approximately 1.4 kb fragment corresponding to the coding se-
quence and 5’UTR of PBANKA_1449300 was PCR amplified from P.
berghei genomic DNA with primers CPW2-F (TTGGGCTGCAGTCGAGA
TAACAATTGAACTTGGTAAAGTAGCA) and CPW2-R (ATGAGGGCCCC
TAAGCTCAATTTTTGAACTTGTATAAAAGAATAATTAATTT) and
cloned into SalI/HindIII-digested plasmid pBS-EGFP-hDHFR to give
pBS-CPW2/GFP. The plasmid was linearized with HindIII before gene
targeting by single crossover homologous recombination.
An approximately 2.4 kb fragment corresponding to the coding se-
quence and 5’UTR of PBANKA_1218300 was PCR amplified from P.
berghei genomic DNA with primers CPW3-F (TTGGGCTGCAGTCGAGC
AATATGGGATTGCGATTTG) and CPW3-R (ATGAGGGCCCCTAAGCTC
ACATCGATTATTGCCCCTG) and cloned into SalI/HindIII-digested
plasmid pBS-EGFP-hDHFR to give pBS-CPW3/GFP. The plasmid was
linearized with BlpI before gene targeting by single crossover homo-
logous recombination.
An approximately 1.5 kb fragment corresponding to the coding se-
quence and 5’UTR of PBANKA_1015400 was PCR amplified from P.
berghei genomic DNA with primers CPW4-F2 (TTGGGCTGCAGTCGAG
ACAATTTTTTATTGTTAAAATAGATAATGG) and CPW4-R (ATGAGGG
CCCCTAAGCTGATAACAAGGTTTGAAACTATTTCCCC) and cloned into
SalI/HindIII-digested plasmid pBS-EGFP-hDHFR to give pBS-CPW4/
GFP. The plasmid was linearized with ClaI before gene targeting by
single crossover homologous recombination.
2.10. Generation of PHL protein targeting constructs
An approximately 1.5 kb fragment corresponding to the coding se-
quence and 5’UTR of PBANKA_0417200 was PCR amplified from P.
berghei genomic DNA with primers PH1-F (TTGGGCTGCAGTCGAGGT
ACCACAAAACAATTGTCATAAAATAGTTCTTG) and PH1-R (ATGAGG
Fig. 1. Proteomics approach used to determine the LAP3 interactome. A: Workflow of the different experimental steps used in the analysis (see Materials and
Methods for details). B: Hierarchical clustering of relative LFQ profiles of the putative LAP3 interactome identified (see Table 1 for annotation). Replicate GFP
pulldown samples from Plasmodium berghei ookinetes expressing GFP-tagged LAP3 with or without in vitro crosslinking before pulldown are included, as well as two
negative controls obtained from LAP3-KO parasites. LAP3 interactome proteins are largely absent in the non-crosslinked samples and negative controls.
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GCCCCTAAGCTCATATCGTTATCGTTTTCTTCATTG) and cloned into
SalI/HindIII-digested plasmid pBS-EGFP-hDHFR to give pBS-PH1/GFP.
The plasmid was linearized with HindIII before gene targeting by single
crossover homologous recombination.
An approximately 1.8 kb fragment corresponding to the coding se-
quence and 5’UTR of PBANKA_0704800 was PCR amplified from P.
berghei genomic DNA with primers PH2-F (TTGGGCTGCAGTCGAGGT
ACCATGCGCATTTATAATATACATAAATAAG) and PH2-R (ATGAGGG
CCCCTAAGCTCAAATTATCATCATCATTATCTTCATATTCTTC) and
cloned into SalI/HindIII-digested plasmid pBS-EGFP-hDHFR to give
pBS-PH2/GFP. The plasmid was linearized with ClaI before gene tar-
geting by single crossover homologous recombination.
An approximately 2.0 kb fragment corresponding to the coding se-
quence and 5’UTR of PBANKA_0704900 was PCR amplified from P.
berghei genomic DNA with primers PH3-F (TTGGGCTGCAGTCGAGGT
ACCATTTCTTATTAATAGACAAAACAAAAATAAT) and PH3-R (ATGA
GGGCCCCTAAGCTCTTAAGAGAAATATTTGGATTACTGCTTTT) and
cloned into SalI/HindIII-digested plasmid pBS-EGFP-hDHFR to give
pBS-PH3/GFP. The plasmid was linearized with NheI before gene tar-
geting by single crossover homologous recombination.
An approximately 1.8 kb fragment corresponding to the coding se-
quence and 5’UTR of PBANKA_0902900 was PCR amplified from P.
berghei genomic DNA with primers PH4-F (TTGGGCTGCAGTCGAGGT
ACCTTTGTACATACATTCAAAAGGCG) and PH4-R (ATGAGGGCCCCT
AAGCTGGTCTCTGCTTTTATGGAAACTAAAAAA) and cloned into SalI/
HindIII-digested plasmid pBS-EGFP-hDHFR to give pBS-PH4/GFP. The
plasmid was linearized with ClaI before gene targeting by single
crossover homologous recombination.
2.11. Generation of TPM2 targeting construct
The entire coding sequence of PBANKA_1104100 plus ca. 0.6 kb of
upstream sequence was PCR amplified from genomic DNA with primers
pDNR-110410-F (ACGAAGTTATCAGTCGAGGTACCGCTCAAACTATTC
CTCCTCAATC) and pDNR-110410-R (ATGAGGGCCCCTAAGCTGTTTA
TTCTATATACAACAGTGATTAAATATACAATG) and cloned into SalI/
Table 1
Putative LAP3 interactome of Plasmodium berghei.
Protein ID Annotation MG-SG transition1 Significantly reduced Reference
1 PBANKA_1319500 LCCL domain-containing protein (LAP4) −0.92 No power [12]
2 PBANKA_1315300 LCCL domain-containing protein (LAP5) −1.57 No power [12]
3 PBANKA_0417200 PH domain-containing protein n/a n/a [43]
4 PBANKA_0704900 Crystalloid-specific PH domain-containing protein, putative −0.29 No [32]
5 PBANKA_0704800 Conserved Plasmodium protein, unknown function n/a n/a
6 PBANKA_1233600 Secreted ookinete protein, putative (PSOP13) −2.14 Yes [35]
7 PBANKA_0912500 Conserved Plasmodium protein, unknown function −0.23 No
8 PBANKA_0943400 CPW-WPC family protein −0.77 No power [33]
9 PBANKA_0606200 Blood stage antigen 41–3 precursor, putative −1.07 No power
10 PBANKA_0203600 Conserved Plasmodium protein, unknown function n/a n/a
11 PBANKA_0417600 LCCL domain-containing protein (LAP6) n/a n/a [12]
12 PBANKA_1342300 Conserved Plasmodium protein, unknown function 0.01 No
13 PBANKA_1317200 Pyridine nucleotide transhydrogenase, putative (NTH) −2.41 Yes
14 PBANKA_0807200 Conserved Plasmodium protein, unknown function (POM7) 0.19 No [45]
15 PBANKA_0620300 Conserved Plasmodium protein, unknown function −1.77 Yes
16 PBANKA_1453900 Conserved Plasmodium protein, unknown function n/a n/a
17 PBANKA_1449300 CPW-WPC family protein n/a n/a [33]
18 PBANKA_0703300 Conserved Plasmodium protein, unknown function −0.37 No
19 PBANKA_0514900 28 kDa ookinete surface protein (P28) −0.27 No [39]
20 PBANKA_1460700 Dipeptidyl aminopeptidase 2 (DPAP2) −0.26 No
21 PBANKA_0926500 Petidase, M16 family, putative n/a n/a
22 PBANKA_1421700 Secreted ookinete protein, putative (PSOP20) n/a n/a [35]
23 PBANKA_1015400 CPW-WPC family protein n/a n/a [33]
24 PBANKA_1463900 HSP20-like chaperone, putative n/a n/a
25 PBANKA_1329400 Conserved Plasmodium protein, unknown function −0.44 No power
26 PBANKA_1112700 Conserved Plasmodium protein, unknown function −0.75 No power
27 PBANKA_1218300 CPW-WPC family protein −0.79 No power [33]
28 PBANKA_0932600 Conserved Plasmodium protein, unknown function −1.14 Yes
29 PBANKA_1353400 Secreted ookinete protein, putative (PSOP7) n/a n/a [35]
30 PBANKA_1434400 Secreted ookinete protein, putative (PSOP17) −1.25 No power [35]
31 PBANKA_1415200 Conserved Plasmodium protein, unknown function n/a n/a
32 PBANKA_1143700 Secreted ookinete protein, putative (PSOP2) −1.57 Yes [35]
33 PBANKA_1243500 Conserved Plasmodium protein, unknown function n/a n/a
34 PBANKA_1338100 Conserved Plasmodium protein, unknown function −1.74 Yes
35 PBANKA_1329900 Conserved Plasmodium protein, unknown function n/a n/a
36 PBANKA_1360400 Conserved Plasmodium protein, unknown function 0.17 No
37 PBANKA_0902900 Conserved Plasmodium protein, unknown function n/a n/a
38 PBANKA_1346300 CPW-WPC family protein −0.55 No [33]
39 PBANKA_0103200 Conserved Plasmodium protein, unknown function n/a n/a
40 PBANKA_0409700 Plasmepsin VI n/a n/a [35]
41 PBANKA_1129000 Secreted ookinete protein, putative (PSOP6) −1.55 Yes [35]
42 PBANKA_1359700 6-cysteine protein (P47) −0.07 No [38]
43 PBANKA_0823200 Conserved Plasmodium protein, unknown function −0.30 No
44 PBANKA_1463000 Osmiophilic body protein G377 −0.71 No power [37]
45 PBANKA_1104100 MOLO1 domain-containing protein, putative (TPM2) −2.17 Yes
46 PBANKA_1352500 CPW-WPC family protein −1.27 No power [33]
47 PBANKA_1113400 Secreted ookinete protein, putative (PSOP12) 0.11 No [35]
48 PBANKA_0813300 Conserved Plasmodium protein, unknown function n/a n/a
49 PBANKA_0515000 25 kDa ookinete surface antigen precursor (P25) −0.42 No [39]
50 PBANKA_1311400 Conserved Plasmodium protein, unknown function −0.26 No
1 Log2-fold change in transition from midgut oocyst to salivary gland sporozoite in pools of null mutant parasites as assessed by [36].
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HindIII-digested pDNR-EGFP by in-fusion cloning to give plasmid
pDNR-TPM2/GFP. The 3'UTR of of this gene was amplified with pri-
mers pLP-110410-F (ATATGCTAGAGCGGCCATGTATGATATGTATTTT
TTGCG) and pLP-110410-R (CACCGCGGTGGCGGCCAATTAAATGAAA
CTGCGGCAC) and the resulting fragment cloned into NotI-digested
pLP-hDHFR by in-fusion cloning to give plasmid pLP-hDHFR/TPM2.
The tpm2-specific sequence from pDNR-TPM2/GFP was transferred to
pLP-hDHFR/TPM2 by Cre/loxP recombination to give the final con-
struct pLP-TPM2/GFP. This plasmid was digested with KpnI and SacII
before gene targeting by double crossover homologous recombination.
2.12. Generation of parasite lines
Parasite transfection, pyrimethamine selection and dilution cloning
were performed as previously described [29,30]. Genomic DNA ex-
traction for diagnostic PCR was performed as previously described [31].
2.13. PCR
PCR amplification was carried out with custom oligonucleotide
primers using Advantage 2 polymerase or Advantage HD polymerase
(Takara Bio) on a thermal cycler typically with 30s denaturation at
94 °C, 30s annealing at 50 °C, and 1min per kb elongation at 62 °C.
2.14. Microscopy
Live parasite samples were assessed, and images captured, using a
Zeiss LSM510 or LSM880 laser scanning confocal microscope using
100× oil objectives and Zeiss Image Browser or ZEN 3.0 software.
3. Results
3.1. Plasmodium LAPs are part of an extended interactome
We previously studied molecular interactions between the six LAPs
using a series of genetically modified parasite lines stably expressing
LAPs individually fused to green fluorescent protein (GFP), combined
with GFP affinity purification and label free quantitative mass spec-
trometry (AP-MS) [7]. This revealed that LAP1, LAP2 and LAP3 form
strong interactions with each other and readily co-purify. In contrast,
LAP4, LAP5 and LAP6 associated more weakly and were only pulled
down with the rest of the LAP complex after in vivo crosslinking [7]. To
identify other proteins interacting with the LAP complex and discover
potential new crystalloid proteins, we made assumptions that such
proteins would behave like LAPs 4–6 in GFP pulldown experiments, and
would also have similar features to LAPs 4–6 with regards to their ex-
pression and subcellular trafficking in the parasite.
For this study, AP-MS was carried out with ookinetes expressing
GFP-tagged LAP3 (LAP3::GFP) that were prepared with and without in
vivo crosslinking (Fig. 1A). This was initially carried out with four
biological replicates each, but following a quality control step assessing
proteome coverage and replicate reproducibility one replicate in each
group was removed because of poor sequence coverage, improving
correlation between replicates (Fig. S1). Protein identification and label
free quantitation of the remaining replicates resulted in an initial data
set of 273 proteins that was subjected to filtering procedures for elim-
inating non-specific interactions (Fig. 1A). As a first filter, proteins were
removed that were present in negative control samples from GFP-ex-
pressing LAP3 knockout parasites (LAP3-KO [2]) (Table S1). Because
the LAPs are trafficked to the crystalloid via the ER and possess an
amino-terminal ER signal peptide sequence [2,10], we also eliminated
proteins that either lacked a predicted ER signal peptide, or that pos-
sessed a carboxy-terminal ER retention signal (Table S1). In addition,
because the LAP-encoding genes are expressed in gametocytes and
show no discernible expression in asexual blood stages [12], proteins
whose transcription was not upregulated in sexual compared to asexual
blood stages were also eliminated (Table S1). Because the LAP-en-
coding genes are predominantly transcribed in female gametocytes,
proteins whose transcript levels were not upregulated in female com-
pared to male gametocytes were also removed (Table S1). Finally, we
removed proteins that were less than 2-fold enriched in the crosslinked
samples (Table S1). These combined filters resulted in a putative LAP3
interactome of 50 proteins (Table 1, Fig. 1B). As expected, the reference
proteins LAPs 4–6 were present in this interactome (Table 1), because
they pull down with LAP3 only after in vivo crosslinking [7]. Also as
expected, LAPs 1–3 were not identified by this analysis (Table 1), be-
cause these proteins are also pulled down from non-crosslinked samples
[7].
We further scrutinized the suitability of our experimental approach
in identifying a genuine interaction network by performing a reciprocal
AP-MS experiment with the newly identified putative interactor
PBANKA_1104100 (Table 1), here named TPM2. To do so, ookinetes
expressing GFP-tagged TPM2 were cultured and purified and then
subjected to AP-MS with and without prior crosslinking. This identified
an initial set of 235 proteins (Table S2), which after applying the same
set of bioinformatics filters yielded a TPM2 interactome of 31 proteins
(Table 2). Even though this interactome was smaller than that identi-
fied for LAP3, probably because of the lower number of replicates
analysed, 27 of its 31 proteins (87%) overlapped with the LAP3 inter-
actome. As expected, all six LAPs were identified (Table 2). This is
because the bait protein TPM2 does not form strong interactions with
the LAPs, and hence these proteins are only pulled down after in vivo
crosslinking. The strong overlap between the TPM2 and LAP3 inter-
actomes provides supporting evidence that they reflect a genuine pro-
tein interaction network.
Table 2
Putative TPM2 interactome of Plasmodium berghei.
Protein ID Annotation
1 PBANKA_1143700 Secreted ookinete protein, putative (PSOP2)
2 PBANKA_1353400 Secreted ookinete protein, putative (PSOP7)
3 PBANKA_1300700 LCCL domain-containing protein (LAP2)
4 PBANKA_1319500 LCCL domain-containing protein (LAP4)
5 PBANKA_1035200 LCCL domain-containing protein (LAP1)
6 PBANKA_0204500 LCCL domain-containing protein (LAP3)
7 PBANKA_0704800 Conserved Plasmodium protein, unknown function
8 PBANKA_0515000 25 kDa ookinete surface antigen precursor (P25)
9 PBANKA_0417200 PH domain-containing protein
10 PBANKA_0514900 28 kDa ookinete surface protein (P28)
11 PBANKA_1317200 Pyridine nucleotide transhydrogenase, putative (NTH)
12 PBANKA_0203600 Conserved Plasmodium protein, unknown function
13 PBANKA_1233600 Secreted ookinete protein, putative (PSOP13)
14 PBANKA_0704900 Crystalloid-specific PH domain-containing protein,
putative
15 PBANKA_0807200 Conserved Plasmodium protein, unknown function
(POM7)
16 PBANKA_0902900 Conserved Plasmodium protein, unknown function
17 PBANKA_0417600 LCCL domain-containing protein (LAP6)
18 PBANKA_1359700 6-cysteine protein (P47)
19 PBANKA_0620300 Conserved Plasmodium protein, unknown function
20 PBANKA_1329400 Conserved Plasmodium protein, unknown function
21 PBANKA_0926500 Peptidase, M16 family, putative
22 PBANKA_0412900 Circumsporozoite- and TRAP-related protein (CTRP)
23 PBANKA_1315300 LCCL domain-containing protein (LAP5)
24 PBANKA_1218300 CPW-WPC family protein
25 PBANKA_1463900 Conserved Plasmodium protein, unknown function
26 PBANKA_1352500 CPW-WPC family protein
27 PBANKA_1342300 Conserved plasmodium protein, unknown function
28 PBANKA_0943400 CPW-WPC family protein, putative
29 PBANKA_0825900 Conserved Plasmodium protein, unknown function
30 PBANKA_0912500 Conserved Plasmodium protein, unknown function
31 PBANKA_1432300 Cell traversal protein for ookinetes and sporozoites
(CelTOS)
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3.2. The LAP interactome is enriched in crystalloid proteins
By analogy to LAP4, LAP5 and LAP6 (Table 1), a significant pro-
portion of proteins of the extended LAP3 interactome were expected to
localise in the crystalloid organelle. Indeed, our analysis identified
PBANKA_1317200, a recently characterised membrane-bound NAD(P)
transhydrogenase (NTH) that resides in the crystalloid organelle in P.
berghei [17]. The analysis also identified PBANKA_0704900, a putative
pleckstrin homology (PH) domain-containing protein whose orthologue
in P. yoelii was recently shown to reside in the crystalloids [32]. Using
this protein's amino acid sequence in BLAST homology searches, we
identified three paralogues in the Plasmodium genome, namely
PBANKA_0417200, 0902900 and 0704800 (Fig. 2A). These were also
present in the LAP3 interactome (Table 1). The genes for two of these
proteins are in fact located tandemly on chromosome 7, pointing to a
relatively recent gene duplication event. Their shared domain only has
weak homology with the archetypal PH domain, and in fact contains a
unique amino acid signature C(X)9W(X)9C (one letter amino acid code,
X= any amino acid) (Fig. 2B). We therefore propose the name PH-like
(PHL) domain-containing proteins for this group of molecules. GFP
tagging of PBANKA_0704900 in transgenic parasites confirmed its lo-
calisation in the crystalloid of P. berghei ookinetes (Fig. 2CD), consistent
with the close relationship between these rodent malaria parasite spe-
cies. Upon GFP tagging in transgenic lines, the other three family
members also displayed a localisation pattern in ookinetes consistent
with crystalloids (Fig. 2CD). Thus, the PHL domain-containing proteins
appear to constitute a novel crystalloid-specific protein family.
Our analysis identified a further two proteins, namely
PBANKA_1352500 and 1346300 (Table 1), which were previously re-
ported to be crystalloid-resident by GFP tagging [33]. These two pro-
teins are part of the nine-member ‘CPW-WPC’ domain-containing pro-
tein family [33,34]. Interestingly, an additional four members of this
family were identified by our analysis of the LAP3 interactome, namely
PBANKA_0943400, 1015400, 1449300 and 1218300 (Table 1). We
generated GFP-tagged parasite lines for the latter four CPW-WPC pro-
teins (Fig. 3A), which revealed that PBANKA_0943400 and 1015400,
too, displayed weak GFP signal with a crystalloid-like distribution in
ookinetes (Fig. 3B). Although we could not detect discernible GFP
signal in ookinetes of the other two parasite lines, possibly due to low
expression levels (data not shown), our findings indicate that at least
several CPW-WPC family members are involved with the crystalloid.
By analogy to LAP4, LAP5 and LAP6 (Table 1), a proportion of
proteins of the extended LAP3 interactome was also expected to phe-
nocopy the LAP null mutants. Indeed, NTH (PBANKA_1317200) was
Fig. 2. Characterization of pleckstrin homology-like (PHL) domain proteins PBANKA_0417200, PBANKA_0704800, PBANKA_0704900 and PBANKA_0902900. A:
Schematic diagram of protein structures with relative positions of the PHL domains and ER signal peptides (red). Protein lengths (amino acids) are indicated on the
right-hand side. B: Alignment of the shared domain reveals a unique amino acid signature C(X)9W(X)9C (one letter amino acid code, X= any amino acid). C: PCR
diagnostic for integration of the GFP-tagged alleles into the target loci gives rise to the expected products of approximately 1.6 kb (PBANKA_0417200, primers
PH1–5’diag (TTATATAATAAATCCTAACACTTCATCG) and GFP-R (GTGCCCATTAACATCACC)); 1.9 kb (PBANKA_0704800, primers PH2–5’diag (AAAGTATGAACG
CATTAAAAAAATC) and GFP-R); 2.1 kb (PBANKA_0704900, primers PH3–5’diag (TACAGGTAAAAAAGATTGGCAT) and GFP-R); and 2.0 kb (PBANKA_0902900,
primers PH3–5’diag (CGATTTTACATTTACTATTTTGTTAAAAAG) and GFP-R). D: Brightfield and fluorescence confocal images of ookinetes expressing GFP-tagged
PBANKA_0417200, PBANKA_0704800, PBANKA_0704900 and PBANKA_0902900, showing localisation in focal spots associated with pigment (arrows) characteristic
of crystalloids. Hoechst DNA staining (blue) labels nuclei. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version
of this article.)
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shown to be required for crystalloid biogenesis and sporozoite forma-
tion in P. berghei [17]. Equally, our analysis identified
PBANKA_1233600 (PSOP13) and PBANKA_0409700 (plasmepsin VI)
(Table 1), both of which have reported loss-of-function phenotypes
characterised by a lack of sporozoite development in the oocyst [35],
which is consistent with a potential crystalloid localisation. A recent
genome-scale barcode study analysed the contribution of over 1300 P.
berghei genes through the life cycle in pools of gene knockout parasites
[36]. Whilst this type of analysis proved useful to identify genes es-
sential for liver stage parasite development, it was shown to be much
less suitable to identify genes that are essential during the diploid and
polyploid life cycle stages (i.e. zygotes, ookinetes and oocysts) due to
heterozygous rescue [36]. Nonetheless, in this barcode analysis NTH
and PSOP13 null mutants (plasmepsin VI was not assessed) displayed
approximately 4- to 5-fold reductions, respectively, in their transition
from midgut oocyst to salivary gland sporozoite (Table 1) [36]. Whilst
these levels of reduction fall well short of the actual reductions (close to
100%) in oocyst to salivary gland sporozoite transition that are ob-
served when the null mutants are assessed on their own [17,35], they
could reflect their null mutant phenotypes in a context of heterozygous
rescue within the mixed population of null mutants. When we assessed
the other proteins in the LAP3 interactome by this analysis, a further six
proteins were identified that displayed statistically significant and
greater than 2-fold reductions in oocyst to salivary gland sporozoite
conversion upon knockout, namely PBANKA_0620300, 0932600,
1338100, 1143700, 1129000, and 1104100 (Table 1) [36]. These are
prime candidates to constitute additional crystalloid proteins. To test
this hypothesis, we generated a parasite line expressing a GFP-tagged
version of PBANKA_1104100, named TPM2/GFP (Fig. 4). This protein
possesses a central TPM domain named after its founding proteins
TLP18.3, Psb32 and MOLO-1 (Pfam 04536), as well as a transmem-
brane helix near its carboxy terminus (Fig. 4A). Its GFP tagging in
transgenic P. berghei revealed a clear crystalloid-like localisation in
ookinetes (Fig. 4D), indicating that this protein indeed resides in the
crystalloids.
Although many proteins in the LAP3 interactome constituted known
or novel crystalloid constituents, some proteins have other reported
subcellular destinations including osmiophilic bodies [G377
(PBANKA_1463000) [37]]; micronemes [PSOP7 (PBANKA_1353400)
[35]]; and the plasma membrane [P47 (PBANKA_1359700) [38]; P25
(PBANKA_0515000) and P28 (PBANKA_0514900) [39]] (Table 1, Table
S2). One explanation is that these non-crystalloid proteins interact
transiently with the LAP complex whilst in the ER, and have been
pulled down from contaminating zygotes that did not complete trans-
formation into ookinete. In support for this, several putative ER-re-
sident ‘housekeeping’ proteins with roles in protein folding were also
found enriched in the crosslinked samples, including Hsp70/BiP
(PBANKA_0818900), endoplasmin/Hsp90 (PBANKA_1437300), Hsp110
(PBANKA_1357200), HspJ2 (PBANKA_0938300) and two putative
protein disulphide isomerases (PBANKA_0942500 and
PBANKA_0702800) (Table S1).
4. Discussion
Affinity purification combined with mass spectrometry (AP-MS) is a
well-established technology for determining complexes and inter-
actomes of a target protein, but is often hampered by non-specific
protein contamination that can cause considerable background and
complicate interpretation of outcomes [40]. We have used this tech-
nology here to determine a putative interactome of LAP3, an estab-
lished protein of the crystalloid organelle in malaria parasites, and have
included several refinement steps to reduce background. Refinements
were based on two concepts: (i) most protein interactions are weak or
transient and will only be identified through in vivo crosslinking; (ii)
most proteins in the organelle share a similar expression and subcellular
trafficking strategy. This approach allowed us to determine a putative
LAP3 interactome of some 50 proteins (Table 1), which we show is
enriched in both known and novel crystalloid constituents. Background
proteins identified from our negative LAP3-KO controls were also re-
moved by our bioinformatics filters (Table S1), indicating that the latter
were successful in depleting non-specific interacting proteins. Con-
taminants were further eliminated by quantitative comparison of
crosslinked vs non-crosslinked samples (Fig. 1A). This step assumes that
common contaminants are affinity-purified from both crosslinked and
non-crosslinked samples and cancel each other out. By contrast, puta-
tive interactors are likely to be enriched in the crosslinked samples and
can be identified accordingly, as shown previously for the known in-
teractors LAP4, LAP5 and LAP6 [7]. The repertoire of proteins that are
present in the ER at the same time as LAP3 far exceeds the number of
proteins in the interactome, indicating that false identification of con-
taminants that interact ‘accidentally’ with the LAP3 complex was low.
Our findings indicate that many crystalloid proteins physically in-
teract to form an intricate protein complex that extends beyond the six
LAPs. What could be the biological significance of this? The crystalloid
is a short-lived organelle that forms in ookinetes by coordinated as-
sembly of small ER-derived vesicles, a process that is itself dependent
Fig. 3. Characterization of CPW-WPC domain proteins PBANKA_1015400,
PBANKA_0943400, PBANKA_1449300 and PBANKA_1218300. A: PCR diag-
nostic for integration of the GFP-tagged allelles into the target loci gives rise to
the expected products of approximately 1.7 kb (PBANKA_1015400, primers
CPW4–5’diag (AAGACAGTAAATACAATCCATAGGTC) and GFP-R (GTGCCCAT
TAACATCACC)); 2.4 kb (PBANKA_0943400, primers CPW1–5’diag (CCATATT
ATGACTTTCGAACCC) and GFP-R); 1.6 kb (PBANKA_1449300, primers
CPW2–5’diag (CTTACACAAAATGGTATAAACAATTTTTC) and GFP-R); and
2.7 kb (PBANKA_1218300, primers CPW3–5’diag (CGAGTCCGAAAAGGTATA
CATATG) and GFP-R). B: Brightfield and fluorescence confocal images of oo-
kinetes expressing GFP-tagged PBANKA_1015400 and PBANKA_0943400,
showing localisation in focal spots associated with pigment (arrows) char-
acteristic of crystalloids. GFP-tagged PBANKA_1449300 and PBANKA_1218300
did not show discernible GFP fluorescence (not shown). Hoechst DNA staining
(blue) labels nuclei. (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
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on the synthesis of some of its protein constituents like the LAPs, NTH,
and the S-acyl transferase DHHC10 [2,4,16,17]. Crystalloid proteins are
trafficked via the ER, but specific sorting signals for the organelle have
not been identified [10]. One explanation is that proteins destined for
the organelle already interact in the ER to ensure that they are traf-
ficked together, thus eliminating the need for individual proteins to
possess specific crystalloid targeting signals. Interactions between LAPs
already occur before crystalloid formation [7,8]. The formation of a
‘crystalloid protein complex’ in the ER could also explain the pheno-
copy of null mutants of structurally and functionally unrelated crys-
talloid proteins, including DHHC10, NTH and the LAPs [1–4,16,17,41]:
protein interactions within this complex could be highly constrained,
and the removal or structural alteration of certain protein components
could therefore compromise complex formation or functionality, in turn
affecting crystalloid biogenesis and the downstream process of spor-
ogony. Structural modifications of LAP family members have indeed
been shown to change their ability to interact with one another [7] and
to impact on crystalloid biogenesis [2,4,7,15]. Our recent demonstra-
tion that NTH structural knockout parasites do not form crystalloids,
while structurally intact but enzymatically inactive NTH is able to
support crystalloid biogenesis [17], also supports this hypothesis.
Notable among the new crystalloid proteins identified in this study
are two groups of proteins that, like the LAPs, share protein domains:
CPW-WPC domain- and PHL domain-containing proteins. The dis-
tribution of both these domains among organisms matches that of the
LCCL domain and is largely restricted to apicomplexans and chro-
merids. PH domains are common in eukaryotic proteins and are im-
plicated in binding to phosphatidylinositol lipids within biological
membranes, and to several proteins such as protein kinase C and het-
erotrimeric G proteins [42]. However, we argue that the distant
homology of the PHL domain reported here (Fig. 1) with the archetypal
PH domain, combined with its unique distribution among organisms,
more likely points to unique functions of this protein family specific to
apicomplexan parasites. Our GFP tagging of PHL protein
PBANKA_0704900 confirmed a localisation in the crystalloid (Fig. 2) in
agreement with that of its P. yoelii orthologue [32]. However, the
crystalloid localisation of PHL protein PBANKA_0417200 shown here
(Fig. 2) disagrees with its previously reported localisation on the plasma
membrane of P. berghei ookinetes [43]. One explanation for this dis-
crepancy is that the earlier study employed immunofluorescence using
antibodies raised against the recombinantly expressed antigen to loca-
lise the protein. This could have resulted in non-specific binding to the
ookinete surface, which is known for its strong adhesive properties
[39]. Kou and colleagues reported a loss-of-function phenotype for
PBANKA_0417200 consisting of only modest reductions (1.5- to 2-fold)
in gametocyte formation, ookinete conversion and oocyst numbers
[43]. Moreover, no loss-of-function phenotype was found associated
with knockout of the PBANKA_0704900 orthologue in P. yoelii [32].
Collectively, these findings indicate that the PHL domain-containing
proteins have redundant functions, at least at individual level. The
function of the CPW-WPC domain is also unknown. The entire cpw-wpc
gene family in Plasmodium is translationally silenced in gametocytes
and activated during ookinete formation, suggesting specific roles in
parasite transmission [33]. The crystalloid localisation of CPW-WPC
protein PBANKA_1352500 as determined by GFP tagging in live para-
sites [33] disagrees with the reported surface localisation of its P. yoelii
orthologue in zygotes and ookinetes as was determined by indirect
immunofluorescence with antibodies raised against recombinant an-
tigen [34]. This discrepancy could reflect differences between these
parasite species, or between the different methods used to determine
the proteins' localisation. The P. yoelii orthologue of PBANKA_1352500
did not display a loss-of-function phenotype [34], indicating that there
is also functional redundancy within the CPW-WPC domain-containing
protein family.
Fig. 4. Characterization of TPM domain protein PBANKA_1104100 (TPM2). A: Predicted structure showing ER signal peptide (red), TPM domain and C-terminal
transmembrane domain (blue), produced with Simple Modular Architecture Research Tool (http://smart.embl-heidelberg.de). B: Schematic diagram of the un-
modified (parental) and modified tpm2 allele in parasite lines TPM2/GFP. The tpm2 gene is indicated with coding sequence (wide grey bars, introns not shown) and 5′
and 3′ untranslated regions (UTRs) (narrow grey bars). Also indicated are the relative positions of the GFP module (gfp); the human DHFR selectable marker gene
cassette (hdhfr); and primers used for diagnostic PCR amplification (P1-P3). Primer P2 sequence is not present within the targeting vector. Sizes of PCR products are
also indicated. C: Diagnostic PCR for integration into the target locus with primers P3 (ACAAAGAATTCATGGTTGGTTCGCTAAACT) and P2 (CATCTTGAGGTATT
TGTGCATATTC), giving rise to a 1.9 kb product (top panel). Diagnostic PCR with primer pair P1 (ACGAAGTTATCAGTCGAGGTACCGCTCAAACTATTCCTCCTCA
ATC) and P3 amplified an approximately 3.4 kb fragment from the parental WT parasites, and a 7.0 kb fragment in the TPM2/GFP parasites, confirming absence of
the unmodified allele in the transgenic parasite line (bottom panel). D: Brightfield and GFP fluorescence images of a live ookinete of parasite line TPM2/GFP,
showing localisation in focal spots associated with pigment (arrows) characteristic of crystalloids. (For interpretation of the references to colour in this figure legend,
the reader is referred to the web version of this article.)
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The recent genome-scale barcode study used to analyse the pheno-
types of over 1300 P. berghei genes through the life cycle is, as a result
of heterozygous rescue, poorly suited to identify genes that are essential
during the diploid and polyploid life cycle stages (i.e. zygotes, ookinetes
and oocysts) [36]. Nonetheless, cross-referencing the proteins in our
LAP3 interactome with the loss-of-function phenotype for midgut oo-
cyst to salivary gland sporozoite transition (Table 1), indicates that
genes with essential roles in sporogony can potentially be identified
despite the real loss-of-function phenotypes observed with the in-
dividual knockout lines being masked. This is best illustrated by NTH
and PSOP13 null mutants, which still show significant reductions in
salivary gland sporozoite numbers in spite of heterozygous rescue
(Table 1). However, when we used this analysis to assess null mutants
of the LAPs, which are also known to have highly impaired sporogony,
only LAP2 and LAP5 passed this screen (reductions of 1.2-, 4-, 1.9- and
3-fold, respectively, for LAP1, LAP2, LAP4 and LAP5. LAP3 and LAP6
were not assessed) [36] (Table 1). The latter exemplifies the known
limitations of the barcode screen for identifying genes that are either
important for sporozoite formation, or for their colonization of the
salivary glands [36]. In total, our LAP3 interactome contains 11 pro-
teins (including LAP5, NTH and PSOP13) that display greater than 2-
fold reductions in midgut oocyst to salivary gland sporozoite transition
using the high throughput null mutant screen, of which 8 values have
sufficient power to be statistically significant (Table 1). One of these is
the TPM domain protein PBANKA_1104100, which we here demon-
strate by GFP tagging to be crystalloid-resident (Fig. 4). In fact, the
latter protein is a structural paralogue of PBANKA_0720900 that was
reported to be crystalloid-resident and required for sporogony in a
previous study [41]. In Arabidopsis, phosphatase activity was demon-
strated in vitro for a TPM domain-containing protein of the thylakoid
lumen [44], suggesting that these TPM proteins may constitute crys-
talloid-specific protein phosphatases.
Information obtained from PlasmoDB reveals that less than half the
proteins of the LAP3 interactome have functional annotation (Table
S2), which somewhat limits the functional insight that we can gain of
the molecular mechanisms that underlie the role of the crystalloid in
sporogony. Nonetheless, the new molecules identified will form a useful
platform for better understanding these processes through their more
in-depth functional characterization in follow-on studies.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.jprot.2020.103925.
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